Structural and Evolutionary Dynamics of Zoonotic Viral Glycoproteins: Integrating Molecular Modeling, Sequence Surveillance, and Receptor Binding Prediction

Introduction

Zoonotic viral glycoproteins are the molecular determinants of host range, tissue tropism, and cross-species transmission potential in emerging viral pathogens of veterinary and public health concern. These surface-exposed proteins mediate the critical initial step of infection: attachment to host cell receptors and subsequent membrane fusion [1, 2]. Understanding the structural and evolutionary dynamics of these glycoproteins is essential for predicting spillover risk, designing veterinary vaccines, and developing therapeutic interventions [3, 4]. In veterinary medicine, influenza A virus hemagglutinin (HA), coronavirus spike (S) protein, and henipavirus attachment (G) and fusion (F) glycoproteins represent paradigmatic examples of class I fusion machines that undergo extensive conformational rearrangements during entry [2, 5].

Computational approaches have become indispensable for dissecting the biophysical constraints acting on viral glycoproteins and for anticipating how mutations alter receptor binding specificity and affinity [1, 6]. This review integrates homology modeling, molecular dynamics simulations, protein-protein docking, and phylogenetic surveillance to present a unified framework for analyzing zoonotic glycoprotein evolution and receptor binding prediction in a veterinary context.

Structural Constraints and Limited Adaptive Space

Viral glycoproteins are subject to multiple selective pressures, including host receptor recognition, immune evasion, and structural stability [1]. Herzig et al. demonstrated that the SARS-CoV-2 spike protein operates under severe structural constraints that limit the accessible sequence space for adaptive mutations [1]. Using a combination of evolutionary sequence analysis and structural modeling, they identified conserved contact networks within the spike trimer that restrict compensatory mutations. This concept of limited adaptive space has direct veterinary implications: for glycoproteins of animal coronaviruses (e.g., porcine epidemic diarrhea virus, feline coronavirus), similar constraints may govern the emergence of variants with altered host tropism [1, 3].

Structural constraints are often quantified through residue coevolution analysis and free energy perturbation calculations. Mutations that disrupt conserved hydrogen bond networks or hydrophobic core packing are typically destabilizing and require compensatory substitutions elsewhere in the protein to restore fitness [1, 5]. These findings underscore the utility of structure-based fitness landscapes for predicting which glycoprotein positions are most likely to tolerate changes that could lead to zoonotic spillover.

Evolutionary and Structural Analysis of Influenza A Hemagglutinin

Influenza A virus HA is the primary determinant of receptor binding specificity, distinguishing between avian-type alpha-2,3-linked sialic acid receptors and mammalian-type alpha-2,6-linked receptors [2, 6]. Singh et al. performed a comprehensive evolutionary and structural analysis of H5N1 clade 2.3.4.4b viruses using sequence mining of hemagglutinin, nucleoprotein, and neuraminidase genes across multiple avian and mammalian hosts [2]. Their analysis revealed that the HA receptor binding domain (RBD) exhibits lineage-specific substitutions that modulate binding pocket geometry and electrostatic potential. For example, mutations at positions 226 and 228 (H3 numbering) are well-known switches that alter sialic acid linkage preference [2, 6].

The integration of phylogenetic surveillance with structural modeling allowed the authors to predict which circulating avian lineages possess HA variants with enhanced mammalian receptor affinity [2]. This approach is directly applicable to veterinary surveillance programs that monitor H5N1 outbreaks in poultry and wild birds, as it provides a rational basis for prioritizing strains with higher spillover risk [2]. Computational analysis of HA evolution also benefits from large-scale sequence databases such as GISAID, which enable real-time tracking of antigenic drift and glycosylation site turnover [6].

Structure-Based Identification of Vertebrate Susceptibility

Predicting which animal species are susceptible to a given zoonotic virus is a cornerstone of veterinary risk assessment. Kaushik et al. developed a novel structure-based approach to identify vertebrate susceptibility to SARS-CoV-2 by analyzing the conservation of key interfacial residues in the angiotensin-converting enzyme 2 (ACE2) receptor across 400 vertebrate species [3]. Their method combined homology modeling of ACE2 orthologs with protein-protein docking simulations against the SARS-CoV-2 spike RBD. The computed binding energy correlated with experimental measurements of viral entry in cell lines derived from different species, including companion animals (cats, dogs) and livestock (cattle, pigs) [3].

This structure-based pipeline can be generalized to other zoonotic glycoprotein-receptor pairs. For example, the henipavirus G protein binds ephrin-B2 and ephrin-B3 receptors; homology models of ephrin orthologs from bat, swine, and equine species can be used to predict cross-species binding affinity [4]. Such predictions inform targeted surveillance in animal reservoirs and intermediate hosts, thereby aiding the design of veterinary biosecurity measures [3].

Rabies Virus Glycoprotein and Host Receptor Binding

Rabies virus (RABV) glycoprotein (G) is the sole surface protein responsible for receptor attachment and pH-dependent membrane fusion [4]. Khalifa et al. combined structural bioinformatics and evolutionary analysis to investigate how RABV G interacts with host receptors, including the nicotinic acetylcholine receptor, neural cell adhesion molecule, and the low-affinity nerve growth factor receptor [4]. Their work demonstrated that the RABV G ectodomain contains a conserved receptor binding site that is structurally distinct from the fusion loop. Mutations in this region can alter neurotropism and virulence in different mammalian hosts, including dogs, foxes, and bats [4].

The study also employed sequence surveillance across RABV isolates from multiple host species to identify positively selected residues in the glycoprotein [4]. These sites frequently map to exposed loops that may be under immune pressure or involved in host adaptation. For veterinary diagnostics, tracking glycoprotein evolution is critical for updating vaccine strains used in animal rabies control programs [4].

Mutation Effects on Receptor Binding Affinity

Single amino acid substitutions in viral glycoproteins can dramatically increase receptor binding affinity and thus enhance viral infectivity in new hosts. Ou et al. characterized the V367F mutation in the SARS-CoV-2 spike RBD, which arose during early human transmission and increased binding to human ACE2 by approximately 10-fold [5]. Using surface plasmon resonance and pseudovirus entry assays, they confirmed that the mutation stabilizes the RBD-ACE2 interface through additional hydrophobic contacts. Structural modeling revealed that the substitution at position 367, located in a loop region, reorients neighboring side chains to optimize complementarity with the receptor [5].

In a veterinary context, analogous mutations have been documented in influenza HA (e.g., Q226L) that switch sialic acid preference and enable efficient replication in mammals [2, 6]. Computational screening of glycoprotein mutations, using tools such as deep mutational scanning combined with free energy perturbation, can prioritize which variants warrant experimental testing. This approach is increasingly integrated into surveillance pipelines for avian influenza and emerging coronaviruses in animal populations [1, 5].

Glycosylation Signatures as Ecological Spillover Markers

Glycosylation of viral glycoproteins plays a dual role in shielding immunogenic epitopes and modulating receptor binding [6]. Kim et al. examined the glycosylation patterns of influenza A HA and neuraminidase across different host reservoirs (avian, swine, human) and demonstrated that the number and position of N-linked glycan sites serve as a signature for ecological adaptation [6]. For instance, avian adapted HAs generally possess fewer glycosylation sites near the receptor binding pocket compared to human adapted strains, because additional glycans can sterically hinder access to alpha-2,6-linked receptors [6].

The authors used sequence data mining and structural mapping to show that acquisition or loss of glycosylation sites correlates with host switching events [6]. In veterinary surveillance, monitoring glycosylation site turnover in HA and NA provides an early warning signal for strains that may be adapting to mammalian hosts. This information is directly applicable to risk assessment for influenza pandemics originating from swine or poultry [2, 6].

Integrated Computational Workflow

The methods described above can be combined into a coherent computational pipeline for analyzing zoonotic glycoproteins. The following Mermaid diagram illustrates the workflow from sequence acquisition to risk prediction.

flowchart TD
    A[Sequence Surveillance], > B[Phylogenetic Analysis & Selection Detection]
    B, > C[Homology Modeling / AlphaFold2]
    C, > D[Molecular Dynamics Simulations]
    D, > E[Receptor Docking & Binding Free Energy Calculation]
    E, > F[Glycosylation Site Mapping]
    F, > G[Integration with Host Receptor Ortholog Models]
    G, > H[Spillover Risk Prediction]
    H, > I[Vaccine Strain Selection & Surveillance Prioritization]

Each step in this workflow leverages publicly available bioinformatics resources. Homology modeling principles are covered in the article on Homology Modeling: Principles and Practices. For detailed protocols on molecular dynamics simulations, refer to GROMACS Molecular Dynamics: Setting Up, Simulating, and Analyzing Protein-Water Systems. The Structural Bioinformatics of Viral Glycoproteins article provides additional background on glycoprotein architecture.

Table: Key Zoonotic Glycoproteins and Computational Methods

Sequence Surveillance and Data Integration

Real-time sequence surveillance through platforms such as GISAID (for influenza and SARS-CoV-2) and other public repositories is fundamental to the computational framework [6]. Phylogenetic trees built from glycoprotein sequences allow identification of emerging clades with specific amino acid signatures. The Evolutionary Dynamics and Computational Modeling of Viral Mutation Rates article describes how mutation rates and selection pressures can be quantified.

For veterinary applications, linking glycoprotein sequence data with host species metadata is essential. The Zoonotic Spillover Pathways and Receptor Binding Evolution in Bat Reservoirs article provides a case study of how bat coronavirus spike protein evolution is monitored. Similarly, the Structural Dynamics of Avian Influenza Hemagglutinin: Molecular Modeling and Receptor Binding Predictions for Pandemic Risk Assessment article offers a focused discussion on HA modeling.

Future Directions and Conclusion

Advances in deep learning based structure prediction, such as AlphaFold2, have revolutionized the ability to model glycoprotein structures even in the absence of experimental templates [1, 3]. The article on AlphaFold Structure Prediction Server: Structural Analysis and Computational Methodologies in Bioinformatics details the methodology. Combined with molecular dynamics simulations that capture conformational ensembles, these tools enable predictions of receptor binding kinetics under physiologically relevant conditions.

Integrating machine learning for variant effect prediction on protein stability further refines risk assessment [5]. The Machine Learning for Variant Effect Prediction on Protein Stability article discusses relevant algorithms. As genomic surveillance expands in veterinary settings, the pipeline described here will become a standard component of One Health surveillance systems, guiding vaccine updates and intervention strategies for zoonotic threats.

In conclusion, the structural and evolutionary dynamics of zoonotic viral glycoproteins can be systematically interrogated using homology modeling, molecular dynamics, protein docking, and phylogenetic surveillance. The six studies reviewed herein provide a strong foundation for applying these methods within veterinary virology, enabling evidence based predictions of receptor binding and cross-species transmission risk.

References

[1] Herzig JC, Magwira ML, Lovell SC. Structural Constraints Acting on the SARS-CoV-2 Spike Protein Reveal Limited Space for Viral Adaptation. Genome Biol Evol. 2026. https://pubmed.ncbi.nlm.nih.gov/41876430/

[2] Singh K, Malik YS, Hemida MG. Comprehensive Evolutionary and Structural Analysis of the H5N1 Clade 2.4.3.4b Influenza a Virus Based on the Sequences and Data Mining of the Hemagglutinin, Nucleoprotein and Neuraminidase Genes Across Multiple Hosts. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41011764/

[3] Kaushik R, Kumar N, Zhang KYJ et al. A novel structure-based approach for identification of vertebrate susceptibility to SARS-CoV-2: Implications for future surveillance programmes. Environ Res. 2022. https://pubmed.ncbi.nlm.nih.gov/35460633/

[4] Khalifa ME, Unterholzner L, Munir M. Structural and Evolutionary Insights Into the Binding of Host Receptors by the Rabies Virus Glycoprotein. Front Cell Infect Microbiol. 2021. https://pubmed.ncbi.nlm.nih.gov/34708003/

[5] Ou J, Zhou Z, Dai R et al. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. J Virol. 2021. https://pubmed.ncbi.nlm.nih.gov/34105996/

[6] Kim P, Jang YH, Kwon SB et al. Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs. Viruses. 2018. https://pubmed.ncbi.nlm.nih.gov/29642453/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.